Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transforming Hemophilia Management: Lessons from Gene Therapy Clinical Trials

30 Jun 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Hemophilia Treatment and Research
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40586829
DOI: 10.1007/s12033-025-01464-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transforming Hemophilia Management: Lessons from Gene Therapy Clinical TrialsPMID 40586829Read ↗

Advances in gene therapy for hemophilia: basis, current status, and future perspectivesSemantic proximity Read ↗

The hemophilias--from royal genes to gene therapy.Semantic proximity Read ↗

Researchers welcome $3.5-million haemophilia gene therapy — but questions remainSemantic proximity Read ↗

Gene therapy in hemophilia: the dawn of a new eraSemantic proximity Read ↗

The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the worldSemantic proximity Read ↗

Hemophilia gene therapy comes of ageSemantic proximity Read ↗

Clinical perspective: Advancing hemophilia treatment through gene therapy approachesSemantic proximity Read ↗

Gene Therapy for HemophiliaSemantic proximity Read ↗

Hemophilia Gene Therapy: Approaching the First Licensed ProductSemantic proximity Read ↗

Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EUSemantic proximity Read ↗

Hemophilia gene therapy comes of ageSemantic proximity Read ↗

Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.